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Resolution of organelle docking and fusion kinetics in
a cell-free assay
Alexey J. Merz*† and William T. Wickner†
Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755
Contributed by William T. Wickner, June 25, 2004
In vitro assays of compartment mixing have been key tools in the
biochemical dissection of organelle docking and fusion. Many such
assays measure compartment mixing through the enzymatic mod-
ification of reporter proteins. Homotypic fusion of yeast vacuoles
is measured with a coupled assay of proteolytic maturation of
pro-alkaline phosphatase (pro-ALP). A kinetic lag is observed be-
tween the end of docking, marked by the acquisition of resistance
to anti-SNARE reagents, and ALP maturation. We therefore asked
whether the time taken for pro-ALP maturation adds a kinetic lag
to the measured fusion signal. Prb1p promotes ALP maturation;
overproduction of Prb1p accelerates ALP activation in detergent
lysates but does not alter the measured kinetics of docking or
fusion. Thus, the lag between docking and ALP activation reflects
a lag between docking and fusion. Many vacuoles in the popula-
tion undergo multiple rounds of fusion; methods are presented for
distinguishing the first round of fusion from ongoing rounds of
fusion. A simple kinetic model distinguishes between two rates,
the rate of fusion and the rate at which fusion competence is
lost, and allows estimation of the number of rounds of fusion
completed.
Pho8p  protease B  SNARE  RabYpt  tethering
Membrane docking and fusion events have been measuredby many methods. Among the most commonly used are in
vitro, coupled enzymatic assays of compartment mixing between
two vesicle populations (1). One vesicle population contains a
reporter substrate, and the other vesicle population contains an
enzyme that can covalently modify the reporter substrate. We
call vesicles containing the modifying enzyme ‘‘effector’’ vesicles
and vesicles containing the substrate ‘‘reporter’’ vesicles. Fusion
causes content mixing between effector and reporter vesicles,
allowing the enzyme access to the reporter substrate. The
amount of reporter modified thereby indicates the extent of
fusion.
Coupled transport and fusion assays have made possible the
identification of molecules that mediate vesicle budding, docking
and fusion, and the dissection of the mechanisms by which these
molecules act. However, coupled assays have potential limita-
tions. Treatments that inhibit the reporter system may be
interpreted incorrectly as fusion inhibitors. Moreover, if the
enzymatic processing of the reporter substrate is slow relative to
the docking or fusion reaction of interest, the kinetics of the
processing event will dominate, and thus obscure, the kinetics of
fusion.
We study yeast vacuolevacuole homotypic fusion. A key tool
in our work is a cell-free, coupled enzymatic assay of vacuole
fusion (2). In this assay, the reporter substrate is the enzyme
alkaline phosphatase (ALP), encoded by the PHO8 gene. ALP
is synthesized as an inactive precursor, pro-ALP, and is pro-
cessed into an active form by proteolytic cleavage (3, 4). The
reporter vacuoles contain pro-ALP but are protease deficient.
The effector vacuoles are protease replete but lack pro-ALP.
Content mixing between effector and reporter vacuoles results in
processing of pro-ALP to ALP. In addition to effector–reporter
fusion, effector–effector and reporter–reporter fusion also oc-
curs; the latter events do not yield a signal in the coupled assay.
ALP maturation is monitored by a change of Pho8p mobility in
immunoblots or a colorimetric ALP activity assay (2). The
colorimetric version of the vacuole fusion assay is rapid
and quantitative and will be amenable to high-throughput
experimentation.
Inhibitors have been used in kinetic and staging experiments
to divide the overall vacuole fusion reaction into three major
subreactions: priming, docking, and fusion. In priming, which
can occur before vacuole–vacuole contact, Sec1817p (yeast
NSF-SNAP) consumes ATP to diassemble cis-SNARE com-
plexes on the vacuole membrane (5, 6). The docking step of the
reaction begins with membrane tethering, which depends on
Ypt7p, a Rab-family GTPase (7–9). Upon tethering, Ypt7p:GTP
governs the assembly of a lipid- and protein-enriched subdomain
called the vertex (10, 11). Docking culminates with the formation
of trans-SNARE complexes that span the docking junction and
the SNARE-dependent release of Ca2 from the vacuole lumen
(12). Ca2 release may trigger the final subreaction, fusion (13).
Fusion inhibitors generally exhibit one of three distinct kinetic
profiles, corresponding to action by their target molecules during
priming, docking, or fusion. This kinetics-based taxonomy of
fusion factors and reaction stages is largely, but not completely,
in accord with staging based on blockrelease protocols. How-
ever, several factors may complicate the interpretation of these
experiments. As we show here, vacuoles can undergo multiple
rounds of fusion in vitro, but it has not been possible to
discriminate between the first round and subsequent rounds of
fusion. Moreover, it has not been clear whether pro-ALP
processing is fast or slow relative to the steps of fusion. Slow
pro-ALP processing could distort measurements of fusion ki-
netics; the apparent delay after docking and before fusion might
instead reflect a lag between fusion (content mixing) and
pro-ALP activation.
In this report, we present a detailed analysis of the vacuole
fusion assay system. We show that Prb1p, a vacuolar serine
protease, activates the reporter substrate ALP; this reaction is
fast relative to the fusion reaction. Methods are introduced to
distinguish treatments that block fusion from those that inhibit
the activation of pro-ALP. Finally, we show that modifications of
the fusion assay allow discrimination between a single round of
fusion and ongoing rounds of fusion.
Materials and Methods
Strains, Plasmids, and Growth Conditions. The standard tester
strains used for the vacuole fusion reaction are the reporter
pro-ALP donor BJ3505 [MAT pep4::HIS3 prb1-1.6R his3–200
lys2–801 trp1-101 (gal3) ura3–52 gal2 can1] (14) and the
effectorprotease donor DKY6281 (MAT leu2–3 leu2–112
ura3–52 his3-200 trp1-901 lys2–801 suc2-9 pho8::TRP1) (15).
For some experiments, pho8::neo and pep4::neo derivatives of
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BY4742 (MAT his31 leu20 lys20 ura30) (16) were used in
place of BJ3505 and DKY6281. pCM189 (CEN TetO tTA URA3)
and pCM185 (CEN ARS TetO tTA TRP1) are low-copy vectors
designed for doxycycline-repressible gene expression (17).
pAJM41 and pAJM43 were constructed by ligating the coding
region of PRB1 into pCM189 or pCM185, immediately 3 of the
tTA promoters. pAJM44 and pAJM46 were constructed by
ligating the coding region of PEP4 into pCM189 or pCM185,
immediately 3 of the tTA promoter. BJ2168 (MATa leu2 trp1
ura3–52 prb1–1122 pep4–3 prc1–407 gal2) (14) was used as a
recipient strain for PEP4 and PRB1 complementation experi-
ments: AMY51 carries pCM189, AMY52 carries pAJM41,
AMY53 carries pCM189 and pCM185, AMY54 carries pCM189
and pAJM46, AMY55 carries pAJM41 and pCM185, and
AMY56 carries pAJM41 and pAJM46. DKY6281 was used as
the background for PEP4 and PRB1 overexpression: AMY45
carries pCM189, AMY47 carries pAJM41, and AMY49 carries
pAJM44. The PRB1 overexpresser AMY47 loses viability after
extended growth on selective plates without doxycycline; for this
reason, AMY45, AMY47, and AMY49 were grown in the
presence of 5 gml doxycycline to prevent protease overpro-
duction during routine passage. These strains were grown for
vacuole isolation by first growing 100-ml broth cultures overnight
in synthetic defined-uracil medium without doxycycline. Cells
were harvested by centrifugation, used to inoculate 1-liter cul-
tures in yeast extract peptone dextrose broth, and grown 16 h
at 30°C. In some experiments, recombinant IB2 (150 g per 1.0
OD600 liter of cells) was added at the DEAE dextran treatment
step of vacuole isolation (2) to reduce proteolysis caused by
Prb1p released from ruptured vacuoles, a procedure that signif-
icantly improved the fusion competence of vacuoles derived
from Prb1p overexpressers. Density gradient floatation of the
vacuoles during isolation left most of the added IB2 activity at
the bottom of the Ficoll gradient, along with cell debris.
Fusion and ALP Activity Measurement. A standard 30-l fusion
reaction contained a total of 6 g of vacuoles (3 g of effector
and 3 g of reporter vacuoles), isolated as described (2), 125 mM
KCl, 20 mM K-Pipes (pH 6.8), 6 mM MgCl2, 10 M CoA, 4.5 M
recombinant IB2 (Pbi2p), and 10 nM recombinant his6-Sec18p.
ATP-regenerating system (2) was added from a 10 stock to 1
final. Reactions were incubated at 27°C. For assays containing
different proportions of effectors and reporters, a total of 6 g
of vacuoles per 30-l reaction was always used. ALP maturation
reactions with dilute detergent lysates contained a total of 6 g
of vacuoles (typically 3 g of effector and 3 g of reporter
vacuoles), 125 mM KCl, 20 mM K-Pipes, pH 6.8, 6 mM MgCl2,
and 0.3% (volvol) Triton X-100 detergent.
ALP-dependent formation of nitrophenolate from p-
nitrophenylphosphate was measured by absorbance at 400 nm, as
described (2), except that the assay buffer contained 250 mM
TrisCl (pH 8.5), 0.4% (volvol) Triton X-100, 10 mM MgCl2,
1 mM CaCl2, and 1 mM p-nitrophenylphosphate. In this buffer
at 30°C, crude vacuolar ALP has an apparent KM for p-
nitrophenylphosphate of 260  20 M (mean  95% confidence
interval; data not shown). The ALP assay was used within its
linear range (i.e., it was not substrate limited) under the condi-
tions used in this study. One unit of ALP activation is defined
as an amount of ALP that catalyzes formation of 1 mol of
nitrophenolate product per minute. Vacuole fusion-mediated
ALP activation is normalized to ALP unit per microgram of
effector vacuoles (2). In experiments initiated with different
proportions of effector and reporter vacuoles, the use of this
normalization corrects for the initial amount of reporter vacu-
oles present. ALP activation in detergent lysates is reported as
the increase in active ALP per time (ALP activation unit per
minute). The fusion and ALP maturation data shown are
representative examples from three to five independent exper-
iments, except for the experiment shown in Fig. 2B, which was
done twice.
Microscopy. Microscopy and morphometry were as described
(12). The images shown in Fig. 4 were acquired by wide-field
microscopy, then subjected to high-pass (16-pixel threshold) and
sharpening filters (5  5 hat) to emphasize fine structure in the
fields. Microscopic image analysis was done with IMAGEJ 1.32j
(http:rsb.info.nih.govij), and data were analyzed with JMP
5.0.1a (SAS Institute, Cary, NC).
Modeling and Data Analysis. Modeling and data analysis were done
by using IGORPRO 4.08 (WaveMetrics, Lake Oswego, OR) and
BERKELEY MADONNA 8.19a. We model the coupled fusion assay
with a system of differential equations:
dVfdt  k2  Vf [1]
dVpdt  k1  Vp  Va  Vf [2]
dVadt  k2  Va  Vp  Vf [3]
Vf is the fraction of fusion-competent vacuoles, Vp is the
fraction of effectors (vacuoles containing protease), and Va is
the fraction of reporters (vacuoles containing immature pro-
ALP). k1 is the forward fusion rate constant. k2 is the rate
constant for loss of fusion competence. Both processes are
controlled by mass action and are irreversible. For the traces in
Fig. 4B, Vf was set at a constant value of 1 (k2  0).
A, the amount of activated ALP at time t, is
A  Atotal  	1  
 Va 	tVa 	o [4]
where Atotal is the amount of activatable pro-ALP in a reaction,
determined in an in vitro ALP maturation experiment with
detergent lysates. Typically, Atotal  10 units. Fits of experimen-
tal data to A were done in two steps. An initial fit was done with
simultaneous optimization of k1, k2, and Vf[0], the initial fuso-
genic fraction of vacuoles. A second fit was then performed with
Vf clamped to its mean value from the initial set of fits and with
optimization of k1 and k2.
S, the fold-increase in vacuole surface area (assuming con-
servation of membrane), increases as
dSdt  k1  S  Vf. [5]
R, the number of rounds of fusion, is defined as the average
of fusion events per vacuole in the population, and (again,




Prb1p Mediates ALP Activation. The vacuole fusion assay relies on
Pep4p (protease A)-dependent proteolytic maturation of pro-
ALP (3, 4). We now report that a second protease, Prb1p, is rate
limiting for ALP maturation. Because Pep4p is required for
Prb1p activation, pep4 mutant strains lack both Pep4p and Prb1p
activities (4, 14, 18). Vacuoles isolated from any of several pep4
strains contain pro-ALP but lack significant ALP activity. The
pro-ALP in these vacuoles can be activated in vitro, either by
fusion with protease-replete vacuoles that lack ALP (Fig. 1A) or
by mixing detergent lysates of these vacuole populations (Fig.
1B). ALP activation in detergent lysates is potently inhibited by
inhibitors of protease B (PMSF and IB2) (14), but maturation is
not inhibited by an inhibitor of protease A (pepstatin A) (14). In
fusion experiments with intact vacuoles, the membrane-
permeant inhibitor PMSF blocked ALP maturation, but the
membrane-impermeant inhibitor IB2 had no effect on matura-








tion. Thus, fusion-dependent ALP maturation occurs within the
vacuole lumen as expected and is Prb1p dependent. However,
vacuoles isolated from BY4742 prb1 cells exhibit significant
ALP activity, typically 25% of the activity observed in vacuoles
isolated from the BY4742 parental strain, and overexpression of
plasmid-borne PEP4 complements the ALP maturation defect in
the pep4 prb1 prc1 strain BJ2168 (data not shown). These results
suggest that in vivo ALP activation occurs through two pathways,
both of which depend on Pep4p: a fast pathway that requires
Prb1p and a slow pathway that does not. To test this idea, Pep4p
or Prb1p were overproduced in the PEP4 PRB1 pho8 strain
DKY6281 by introducing episomal copies of PEP4 or PRB1
driven by a strong promoter (see Materials and Methods). Prb1p
overproduction increased the rate of pro-ALP activation in
detergent lysates (0.064  0.018 units per min versus 0.020 
0.004 units per min for vector control; means  SD; n  5
experiments). In contrast, Pep4p overproduction did not alter
the rate of pro-ALP activation in detergent lysates (0.021  0.005
units per min; n  3 experiments). We conclude that when Pep4p
and Prb1p are both present at normal levels, Prb1p is rate
limiting for ALP activation.
ALP Activation Is Fast Relative to the Docking–Fusion Transition. Does
the time taken by Prb1p to activate pro-ALP add a significant
kinetic lag to the in vitro vacuole fusion assay? If such a lag exists,
we might expect that increasing the rate of pro-ALP activation
should increase the apparent rate of fusion, but it should not
influence docking kinetics. To measure the relative rates of
docking and fusion, a kinetics of inhibition assay was used. Two
master fusion reactions were initiated, one containing effector
vacuoles from a control (vector alone) strain and the other
containing effector vacuoles from the Prb1p overproducer.
Protease-deficient reporter vacuoles containing pro-ALP were
present in both fusion reactions. At intervals, aliquots were
withdrawn from the master reactions and placed either in tubes
with anti-Vam3p antibody (which inhibits during docking by
interfering with SNARE protein function) or in tubes held on
ice, which inhibits fusion. ALP activation can occur only after
content mixing, the final step of fusion. If ALP activation is slow
relative to the transition between docking and fusion, acceler-
ated ALP activation should increase the apparent rate of fusion
without changing the kinetics of docking. In other words, the ice
curve should shift left, toward the docking curve. As shown in
Fig. 2A, PRB1 overexpression accelerated ALP activation in
detergent extracts but did not change the observed kinetics of
either docking or fusion. Similarly, PEP4 overexpression had no
detectable effect on the kinetics of fusion-dependent ALP
maturation (data not shown). An assumption central to this
analysis is that most of the Prb1p-containing effector vacuoles
are in fact derived from overexpresser cells. Because PRB1 is
overexpressed from a plasmid and the cells are grown in
nonselective medium for 9 doublings, and because PRB1
overexpressers are relatively slow-growing (doubling time 130
min vs. 105 min for vector control), we measured the rate of
plasmid loss by replica-plating onto selective and nonselective
media. At harvest, 90% of the cells retained the plasmid. These
results suggest that the time taken for ALP activation by Prb1p
does not add a substantial component to the apparent kinetics
of vacuole fusion in vitro.
To increase the sensitivity of this analysis, we synchronized
docking by using priming bypass conditions (Fig. 2B; refs. 12 and
19). A standard reaction is incubated for 20 min with anti-Sec17p
antibody, which prevents priming; the anti-Sec17p block is then
bypassed by addition of a soluble recombinant SNARE,
rVam7p. Upon rVam7p addition, the reaction rapidly loses
sensitivity to anti-Vam3p antibody (Fig. 2B, F; half-time 2
min), and fusion events begin to occur within 1 min (12, 19).
However, ALP is activated more slowly, with a half-time of 24
min (Fig. 2B, E). Again, we reasoned that Prb1p overproduction
should accelerate ALP activation, and thereby increase the
apparent rate of fusion, if postfusion ALP activation is a slow
step. Under priming bypass conditions (Fig. 2B), neither the
acquisition of insensitivity to anti-Vam3p (Fig. 2B, Œ) nor the
activation of ALP (Fig. 2B, ‚) was affected by Prb1p overex-
pression. Thus, postfusion ALP activation by Prb1p is fast
relative to the transition from docking to fusion, and ALP
activation is a faithful kinetic reporter of fusion events.
Assay of Single or Ongoing Rounds of Fusion. Microscopic obser-
vations of vacuole size during in vitro fusion indicate that very
large vacuoles appear in the population (Fig. 3), indicating that
many vacuoles fuse more than once. It would be useful to
discriminate between processes required for a single round of
fusion and for ongoing rounds of fusion. However, light-
microscopic measurement of vacuole size distributions (Fig. 3C)
will systematically underestimate the amount of fusion. First,
vacuolar membrane is not conserved during fusion. In most
fusion events, membrane from the docking junction is lost into
the vacuole lumen (10); as a consequence, the product vacuole
has less membrane surface than its precursors do. Second, many
vacuoles present in the starting population are too small to
accurately measure by light microscopy; these vacuoles can be
observed by electron microscopy (A.J.M., L. Wang, L. Orci, and
W.T.W., unpublished data). If small vacuoles fuse, their fusion
products will repopulate the smallest size classes that can be
Fig. 1. Inhibitor sensitivity of in vitro ALP activation. (A) Fusion-dependent
ALP activation. (B) ALP activation in dilute detergent lysates. Standard reac-
tions were initiated as described in Materials and Methods. Inhibitors were
added either at the start or the end of a 60-min incubation at 27°C. Inhibitor
concentrations were 25 M for IB2, 1 mM for PMSF, 50 M for pepstatin, and
110 mM for anti-Vam3p.
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measured by light microscopy. The formation of very large
vacuoles provides strong evidence that many vacuoles undergo
multiple rounds of vacuole fusion in the cell-free reaction.
However, for the reasons just mentioned, it is difficult to quantify
how many rounds of fusion have occurred in the population as
a whole by using light-microscopic size measurements.
One round of fusion has occurred when, on average, each
vacuole in the starting population has fused once. Upon fusion
with a protease-replete effector vacuole, the pro-ALP in a
reporter vacuole should be completely activated. The conse-
quences of this are diagrammed in Fig. 4A. If protease-replete
effector vacuoles are in excess over pro-ALP-containing re-
porter vacuoles (Fig. 4A, effectors  reporters), the first fusion
event that a reporter vacuole undergoes will likely result in ALP
activation. Conversely, if ALP-containing reporter vacuoles are
in excess over protease-replete effector vacuoles, a reporter
vacuole may undergo multiple rounds of fusion with other
reporter vacuoles before encountering a Prb1p-replete effector
vacuole (Fig. 4A, effectors  reporters). By varying the propor-
tions of effector and reporter vacuoles, we bias the assay toward
detection of either the first round of fusion or ongoing rounds of
fusion.
The effects of varying the proportions of the two vacuole
populations are modeled in Fig. 4B (details are provided in
Materials and Methods). In this simulation, fusion events are
ongoing at a constant rate, with one round of fusion per 33 min
of elapsed time. (Note that after one round of fusion, some
vacuoles have not yet fused, whereas others have fused more
than once.) When a reaction is initiated with protease-replete
effector vacuoles in excess over pro-ALP-containing reporters,
the fraction of protease-replete effectors remains high and
relatively stable (Fig. 4B Left). Under these conditions (e.g., Fig.
4B Right, trace 0.87), only the first round of fusion contributes
substantially to the ALP signal because the first time a reporter
vacuole fuses, it will fuse with an effector. If the reaction is
instead initiated with pro-ALP-containing reporter vacuoles in
excess over protease-replete effectors, repeated rounds of fusion
(and thus content mixing) cause the fraction of protease-replete
effector vacuoles to increase over time (Fig. 4B Left). Under
Fig. 2. Apparent kinetics of fusion are not changed by Prb1p overproduction
in effector vacuoles. Fusion or detergent lysate (Insets) reactions contained
reporter vacuoles obtained from strain BJ3505 and effector vacuoles from
either strain AMY45 (control strain, circles) or AMY47 (Prb1p overproducer,
triangles). (Insets) Graphs show the kinetics of ALP processing in dilute deter-
gent lysates, with the same vacuole preparations used for the fusion experi-
ments in the main graphs. (A) Kinetics of inhibition experiment. Master
reactions were incubated at 27°C. At the intervals shown, 30-l aliquots were
removed from the master reactions and placed on ice (open symbols) or mixed
with anti-Vam3p antibody and incubated at 27°C for the remainder of the 80
min (filled symbols). (B) Kinetics after synchronous docking. Master reactions
were initiated as in A but contained anti-Sec17p IgG added from the start.
After incubation for 20 min at 27°C, recombinant Vam7p (5 M) was added to
the master reactions, and at intervals, 30-l aliquots were removed from the
master reactions and placed on ice (open symbols) or mixed with anti-Vam3p
antibody and incubated at 27°C for the remainder of the 80 min (filled
symbols). The 0 time point in this experiment is the signal obtained with a
reaction not rescued by Vam7p addition and was equivalent to the signal
given in a reaction in which anti-Vam3p was added immediately before
Vam7p. The ALP values are plotted in normalized form; maximum ALP activity
values at 80 min were 3.6 units for the reactions containing control effector
vacuoles (circles) and 4.5 units for the reactions containing Prb1p overpro-
ducer vacuoles (triangles).
Fig. 3. Formation of large vacuoles as a consequence of in vitro fusion. (A
and B) Standard fusion reactions were initiated in the absence or presence of
anti-Vam3p antibody, as indicated, incubated for 120 min at 27°C, stained
with MDY-64 fluorophore, and mounted for microscopy. (C) Vacuole diame-
ters were measured from micrographs, and surface areas were estimated and
plotted as histograms.








these conditions, early fusion events contribute to the ALP signal
less than later fusion events (e.g., Fig. 4B Right, trace 0.07).
The kinetics of ALP maturation were measured in fusion
reactions initiated with various fractions of effector and reporter
vacuoles (Fig. 4C). As expected, faster ALP maturation was
observed with increasing fractions of effector vacuoles, consis-
tent with a first-round bias under these conditions. However,
ALP maturation was even slower than expected in reactions
initiated with low fractions of effector vacuoles (compare Fig. 4
C with B Right). The simplest explanation of this result is that
vacuoles lose fusion competence over time, and indeed, a kinetic
model that incorporates a rate constant for the loss of fusion
competence (Fig. 4D) fits the experimental data reasonably well
(Fig. 4E). We typically find that the decay rate constant (k2) is
smaller than the forward rate of fusion (k1) but is still substantial.
For the experiment shown in Fig. 4 C and D, decay was somewhat
faster than usual, with k1  0.027  0.007 min1 and k2  0.025 
0.009 min1, and 48% of the starting vacuole population was
fusion active (see Materials and Methods). The fusion capacity of
a given vacuole preparation is determined by the initial fraction
of fusion-competent vacuoles and by k1 and k2, the rate constants
for fusion and for decay of fusion competence. In this experi-
ment, 0.7 rounds of fusion occurred in the whole vacuole
population at 120 min; at this time, the reaction was essentially
complete. The vacuoles that were actively fusing (the population
that yields a signal in the ALP assay) underwent 1.5 rounds of
fusion during the 120-min interval.
Discussion
The coupled cell-free assay of vacuole docking and fusion (2)
offers significant experimental advantages, including ease of
genetic manipulation, relatively high throughput, and large
organelle size, which facilitates microscopic analyses. Although
the vacuole fusion assay is most often used in an endpoint
format, kinetic experiments have been used extensively in the
functional characterization of docking and fusion factors. In this
study, we characterized the kinetic response of the ALP assay
and developed methods for discriminating between the first
round of fusion and later fusion events.
The coupled assay of vacuole fusion-mediated content mixing
relies on the proteolytic activation of vacuolar ALP (Pho8p).
Protease inhibitor sensitivities and protease overproduction
experiments indicate that Prb1p, vacuolar protease B, is rate
limiting for ALP maturation in vitro, in both detergent lysates
and intact vacuoles. However, at least some PEP4-dependent
Fig. 4. Quantitative analyses of single and multiple rounds of fusion in the
homotypic vacuole fusion system. (A) Cartoon depicting effects of initiating
fusion reactions with different proportions of effector and reporter vacuoles.
(B) Modeling of the quantitative consequences of varying effector and re-
porter vacuole fractions. Details of the model are given in Materials and
Methods. For these simulations, the fusion rate constant was set at 0.03 min1.
In both panels, the darker traces indicate reactions containing equal fractions
of effector and reporter vacuoles, the standard reaction condition. (Left) The
fraction of total vacuoles that are effectors. Because any vacuole that contains
proteases is an effector, content mixing between effectors and reporters
causes the fraction of effectors to increase over time. When reactions are
initiated with large fractions of effectors, reporter vacuoles will, when they
fuse, almost always fuse with an effector, yielding an ALP signal (Right). Under
these conditions, only the first round of fusion contributes substantially to the
ALP signal. At lower effector fractions, the fraction of effectors increases
dramatically over time (Left), with the consequence that the ALP signal (Right)
increases most rapidly during later fusion events. (C) Raw data from an
experiment in which the initial effector and reporter were varied over a wide
range. Background (ice incubation) values are subtracted from all signals;
these values were 0.16, 0.27, and 1.0 units for reactions containing initial
effector vacuole fractions of 0.025, 0.5, and 0.975, respectively. (D) Modeling
as in B but with the incorporation of a rate constant for irreversible decay of
fusion competence. The downward-sloping trace (Left) shows the decrease in
proportion of fusion-competent vacuoles over time. For these simulations, the
fusion rate constant k1 was set at 0.03 min1, and the rate constant for loss of
fusion competence k2 was set at 0.01 min1. (E) Fits of the model described in
D to the experimental data shown in C. Details are given in Materials and
Methods.
11552  www.pnas.orgcgidoi10.1073pnas.0404583101 Merz and Wickner
ALP maturation occurs in vivo in prb1 mutants. Together, these
observations suggest that ALP can be activated through two
pathways, both of which require protease A (Pep4p). A fast
pathway, probably the dominant pathway in wild-type cells,
requires Prb1p; a slower pathway is Prb1p independent. Over-
production of Prb1p, but not Pep4p, accelerates ALP activation
in vacuole detergent lysates, confirming that Prb1p is rate
limiting for ALP maturation. In contrast to these results, Prb1p
overproduction has no detectable effect on fusion-dependent
ALP maturation. This strongly suggests that ALP maturation in
the vacuole lumen, upon content mixing between effector and
reporter vacuoles, is fast compared to the interval between
docking and fusion. In accord with this conclusion, mature ALP
appears in vivo with a half-time of 6 min (3). This time includes
transport through the endoplasmic reticulum and Golgi complex
to the vacuole, so the proteolytic maturation of pro-ALP takes
6 min. The coupled colorimetric assay is therefore a useful
reporter of fusion kinetics. There is a substantial lag between the
end of sensitivity to inhibitors of Ypt7p and SNARE proteins
and fusion. The reasons for this delay are unclear, but as
discussed below, similar delays are seen in other in vitro fusion
systems, including systems that do not rely on a coupled assay.
Our experiments provide specific methods for evaluating
reagents, especially small-molecule inhibitors, that modulate the
amount of fusion signal observed. ALP processing in detergent
extracts can be used to test whether inhibitors slow or prevent
ALP maturation. For example, the protein phosphatase 1 in-
hibitor microcystin-LR is a putative inhibitor of vacuole fusion
(20, 21). Microcystin-LR inhibition of fusion-dependant ALP
activation has a kinetic profile consistent with inhibition of the
fusion (as opposed to priming or docking) subreaction. However,
microcystin-LR also prevents ALP maturation in dilute deter-
gent lysates and has no apparent effect on fusion-mediated
vacuole size increase or content mixing assayed with fluorescent
probes (unpublished results). Results obtained with microcys-
tin-LR must therefore be interpreted with caution. Other ex-
periments with inhibitors and glc7 mutants have provided inde-
pendent evidence of a role for protein phosphatase 1 in vacuole
fusion (21).
The kinetics of fusion in the vacuole system are comparable to
the kinetics in other in vitro fusion systems. Fusion of predocked
and primed secretory granules in cracked PC12 cell prepara-
tions, for example, takes several minutes (22). In our system, the
first round of fusion occurs with a half-time of 20 min,
including priming and docking (Fig. 4), and many vacuoles
undergo multiple fusion events (Fig. 3). The mechanisms that
cause the loss of fusion competence over time (Fig. 4 C–E) are
unclear. We have begun to screen fusion promoting and inhib-
iting reagents for differential effects on early and late rounds of
fusion. The soluble SNARE Vam7p both accelerates the for-
ward rate of fusion and reduces the rate of inactivation. In
contrast, when GTP is not added to the in vitro reaction, GTP
hydrolysis by the Rab protein Ypt7p appears to increase the rate
at which fusion competence is lost (unpublished data). We
inferred values for k2 by curve fitting in this study, but it is also
possible to directly determine the rate at which fusion compe-
tence is lost. Fusion reactions containing only target or effector
vacuoles are first incubated in separate tubes; at intervals the
effector and reporter reactions are mixed together, and the
remaining fusion capacity is measured. This approach gives
decay rates (e.g., k2  0.02 for figure 8 in ref. 5) similar to the
values inferred from fusion kinetics in the present study.
The events responsible for the observed lag between the end
of sensitivity to Rab- and SNARE-targeted inhibitors, and
fusion (e.g., Fig. 2), are not well understood. Several factors have
been suggested to participate in late stages of vacuole fusion,
including protein phosphatase 1 (20), actin (23), subunits of the
V0 complex of the vacuolar proton ATPase (24), and the
armadillo-repeat protein Vac8p (25, 26). We find that protein
and peptide ligands of phosphoinositides inhibit fusion-
dependent ALP maturation with postdocking kinetics, inhibit
vacuole size increase, and do not inhibit ALP maturation in
dilute detergent lysates (R. Fratti, A.J.M., N. Thorngren, and
W.T.W., unpublished results). Thus, phosphoinositides are
also implicated in postdocking steps of fusion, as proposed
previously (27).
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